 CAMBRIDGE, Mass., Oct. 15, 2021 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced an oral presentation at the European Society of Gene and Cell Therapy ESGCT Annual Virtual Congress taking place October 19-22. The presentation will highlight preclinical advances from the companys retina therapeutic area. 